Archimed
Archimed, officially known as Archimed Group, is a prominent player in the healthcare and technology sectors, headquartered in France. Founded in 2013, the company has rapidly expanded its operations across Europe, focusing on innovative solutions that enhance healthcare delivery and operational efficiency. Specialising in digital health and data analytics, Archimed offers a range of services designed to optimise healthcare processes and improve patient outcomes. Their unique approach combines advanced technology with deep industry expertise, setting them apart in a competitive market. With a strong commitment to quality and innovation, Archimed has achieved significant milestones, establishing itself as a trusted partner for healthcare providers. The company’s dedication to excellence has positioned it as a leader in the digital transformation of the healthcare industry, making a notable impact on the way care is delivered across its operational regions.
DitchCarbon Score
How does Archimed's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Archimed's score of 24 is lower than 61% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Archimed's reported carbon emissions
In 2023, Archimed reported total carbon emissions of approximately 92,853,100 kg CO2e. This figure includes 1,662,330 kg CO2e from Scope 1 emissions, 12,537,410 kg CO2e from Scope 2 emissions, and a significant 78,653,360 kg CO2e from Scope 3 emissions. Comparatively, in 2022, the total emissions were about 55,637,630 kg CO2e, with Scope 1 at 2,480,350 kg CO2e, Scope 2 at 872,140 kg CO2e, and Scope 3 at 52,285,140 kg CO2e. This indicates a notable increase in emissions from 2022 to 2023. In 2021, Archimed's total emissions were approximately 180,295,600 kg CO2e, with Scope 1 emissions at 76,702,500 kg CO2e, Scope 2 at 506,000 kg CO2e, and Scope 3 at 103,087,100 kg CO2e. Despite these figures, Archimed has not disclosed any specific reduction targets or initiatives as part of their climate commitments. The absence of documented reduction strategies suggests a need for further action in addressing their carbon footprint.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project| 2021 | 2022 | 2023 | |
|---|---|---|---|
| Scope 1 | 76,702,500 | 0,000,000 | 0,000,000 |
| Scope 2 | 506,000 | 000,000 | 00,000,000 |
| Scope 3 | 103,087,100 | 00,000,000 | 00,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Archimed is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
